Fractional dose IPV shown effective to stop outbreaks

New study shows fractional dose IPV (fIPV) boosts mucosal immunity in previously OPV-vaccinated children.

A child is vaccinated with fIPV during a campaign in Hyderabad, India. © WHO/Harish Verma
A child is vaccinated with fIPV during a campaign in Hyderabad, India. © WHO/Harish Verma

A new study published this month in the Journal of Infectious Diseases has shown that a single dose of fractional dose inactivated poliovirus vaccine (fIPV) boosts mucosal immunity to a similar degree as a full dose of IPV, in children previously immunized with oral polio vaccine (OPV). During the current IPV shortage, this vaccine is not recommended for outbreak response, however, if it is used, then this finding provides further evidence in support of fIPV rather than full dose IPV at a time of IPV global supply shortage.

The efficacy of fIPV in boosting humoral immunity (offering individual protection against paralytic disease) in comparison to full-dose IPV had already been established, and this dose-sparing approach for routine immunization programmes was subsequently recommended by the Strategic Advisory Group of Experts on immunization (SAGE). Thanks to an increasing number of countries adopting this approach, including Bangladesh, India, Nepal, Sri Lanka, Cuba and Ecuador, there have been significant improvements in the global supply of this vaccine.

These latest findings show that fIPV also has a significant role to play in outbreak response. Mucosal immunity is needed to interrupt person-to-person spread of the virus in a community, so is a critical factor in outbreak response. Used in conjunction with OPV, even a single dose of this formulation could now play a key role in such settings, by rapidly boosting mucosal immunity at a similar level to a full-dose IPV while using a fifth of the vaccine amount. This has clear benefits both on cost and supply.

“Globally, demand for IPV is high and the supply is constrained,” commented Dr Tahir Yousafzai from Aga Khan University in Karachi, Pakistan. “As polio eradication is gradually eliminating OPV, countries will eventually rely solely on IPV, further increasing demand. Fractional IPV can stretch the limited IPV supply and provide similar humoral and mucosal protection when compared to full-dose IPV in children vaccinated with OPV. In addition, it will play an important role in stopping poliovirus transmission, and hence help in the eradication of wild poliovirus and circulating vaccine-derived poliovirus.”

For the post-polio era, the Global Polio Eradication Initiative and its partners are continuing to explore new IPV approaches to ensure an affordable and sustainable supply following global polio eradication, including through the use of IPV vaccine manufactured from Sabin strains or non-infectious materials such as virus-like particles.

Additional information:


Related News

   16/08/2018
Take a look at how the Papua New Guinea Government, the World Health Organization, and partners of the Global Polio Eradication Initiative are responding to the country’s recent outbreak of circulating vaccine-derived poliovirus.
   24/07/2018
Afia is part of one of the biggest female work forces in Afghanistan.
   23/07/2018
How a vaccine refuser became an advocate for polio eradication.
   23/07/2018
Across the Lake Chad Basin, e-Surve technology is revolutionizing the way that the polio programme conducts disease surveillance
   12/07/2018
Honorine Mollard Billard, Polio Eradication Officer at WHO, speaks to us about critical country support to vaccination campaigns in Lao PDR and why it is important for polio-free countries to maintain high immunity.
   12/07/2018
Government launches emergency measures to prevent children from lifelong paralysis.